1
|
Karanfilian B, Tyberg A, Sarkar A, Shahid HM, Simon A, Reinoso K, Bapaye A, Gandhi A, Gadhikar HP, Dorwat S, Raina H, Ansari J, Nieto J, Qadir N, Porfilio MG, Arevalo-Mora M, Puga-Tejada M, Alcivar-Vasquez J, Robles-Medranda C, Ardengh JC, Bareket R, Liao K, Patel R, Pimpinelli S, Gaidhane M, Kahaleh M. Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography. Dig Dis Sci 2024:10.1007/s10620-024-08454-1. [PMID: 38713274 DOI: 10.1007/s10620-024-08454-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2023] [Accepted: 04/17/2024] [Indexed: 05/08/2024]
Abstract
BACKGROUND Viral infections are known to impact the pancreato-biliary system; however, there are limited data showing that the same is true of COVID-19. Endoscopic retrograde cholangiopancreatography (ERCP) can safely be performed in patients with COVID-19 infection, but outcomes of patients with COVID-19 infections and concomitant pancreatic and biliary disease requiring endoscopic intervention are unknown. AIMS This study aims to evaluate the severity of pancreaticobiliary diseases and post-ERCP outcomes in COVID-19 patients. METHODS Patients with pancreato-biliary disease that required inpatient ERCP from five centers in the United States and South America between January 1, 2020, and October 31, 2020 were included. A representative cohort of patients from each month were randomly selected from each site. Disease severity and post-ERCP outcomes were compared between COVID-19 positive and COVID-19 negative patients. RESULTS A total of 175 patients were included: 95 COVID positive and 80 COVID negative. Mean CTSI score for the patients who had pancreatitis was higher in COVID-positive cohort by 3.2 points (p < .00001). The COVID-positive group had more cases with severe disease (n = 41) versus the COVID-negative group (n = 2) (p < .00001). Mortality was higher in the COVID-19 positive group (19%) compared to COVID-negative group (7.5%) even though the COVID-19-negative group had higher incidence of malignancy (n = 17, 21% vs n = 7, 7.3%) (p = 0.0455). CONCLUSIONS This study shows that patients with COVID infection have more severe pancreato-biliary disease and worse post-ERCP outcomes, including longer length of stay and higher mortality rate. These are important considerations when planning for endoscopic intervention. CLINICALTRIALS gov: (NCT05051358).
Collapse
Affiliation(s)
| | - Amy Tyberg
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Avik Sarkar
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Haroon M Shahid
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Alexa Simon
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Karoline Reinoso
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | | | | | | | | | | | | | - Jose Nieto
- Borland Groover Clinic, Jacksonville, FL, USA
| | - Nadim Qadir
- Borland Groover Clinic, Jacksonville, FL, USA
| | | | | | | | | | | | | | - Romy Bareket
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Kelvin Liao
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Roohi Patel
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Sophia Pimpinelli
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Monica Gaidhane
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA
| | - Michel Kahaleh
- Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
| |
Collapse
|